Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Annual rept. 1 Sep 2013-31 Aug 2014
NORTHERN CALIFORNIA INST FOR RESEARCH AND EDUCATION SAN FRANCISCO
Pagination or Media Count:
In Year 5, we completed study enrollment. In total, 203 participants received the study intervention. Safety reports were sent to the study drug sponsor Actelion on a monthly basis. Both blinded and unblinded monitoring visits of study procedures and facilities are ongoing and should be completed by the end of October 2014. We are currently working on data cleaning, quality control efforts, and edit checks and hope to begin analyses in November 2014.
- Medicine and Medical Research
- Stress Physiology